Latest research blogs

Study finds seven per cent of cancer patients carry genetic variants that increase chemotherapy risk — but access to testing appears equal

A new real-world study from Nottingham University Hospitals has found that around seven per cent of cancer patients carry DPYD gene variants that can make standard chemotherapy drugs significantly more toxic.

Read Study finds seven per cent of cancer patients carry genetic variants that increase chemotherapy risk — but access to testing appears equal…
Older articles